Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 49 of 49 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/07/19
End: 07/28/19
Due: 07/28/20
Phase: N/A
Priority: Normal
Start: 12/10/15
End: 12/12/18
Due: 12/12/19
Phase: N/A
Priority: Normal
Start: 09/21/15
End: 11/29/16
Due: 11/29/17
Phase: N/A
Priority: Normal
Start: 11/01/21
End: 09/20/22
Due: 09/20/23
Phase: N/A
Priority: Normal
Start: 08/01/19
End: 05/26/23
Due: 05/26/24
Phase: N/A
Priority: Normal
Start: 07/06/18
End: 05/16/22
Due: 05/16/23
Phase: N/A
Priority: Normal
Start: 07/21/21
End: 07/21/23
Due: 07/21/24
Phase: N/A
Priority: Normal
Start: 04/13/22
End: 02/14/23
Due: 02/14/24
Phase: N/A
Priority: Normal
Start: 03/31/17
End: 11/22/23
Due: 11/22/24
Phase: N/A
Priority: Normal
Start: 09/29/21
End: 08/12/22
Due: 08/12/23
Phase: N/A
Priority: Normal
Start: 03/05/18
End: 11/05/21
Due: 11/05/22
Phase: N/A
Priority: Normal
Start: 11/29/17
End: 04/21/20
Due: 04/21/21
Phase: N/A
Priority: Normal
Start: 10/08/21
End: 09/22/22
Due: 09/22/23
Phase: N/A
Priority: Normal
Start: 08/19/19
End: 09/28/22
Due: 09/28/23
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 09/30/18
Due: 09/30/19
A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults
Phase: N/A
Priority: Normal
Start: 06/18/21
End: 07/10/23
Due: 07/10/24
Phase: N/A
Priority: Normal
Start: 12/07/17
End: 07/23/18
Due: 07/23/19
Phase: N/A
Priority: Normal
Start: 08/27/21
End: 11/24/23
Due: 11/24/24
Phase: N/A
Priority: Normal
Start: 02/18/20
End: 04/25/22
Due: 04/25/23
Phase: N/A
Priority: Normal
Start: 10/05/20
End: 03/02/23
Due: 03/02/24
Phase: N/A
Priority: Normal
Start: 11/26/17
End: 09/23/19
Due: 09/23/20
Phase: N/A
Priority: Normal
Start: 07/16/20
End: 04/09/21
Due: 04/09/22
Phase: N/A
Priority: Normal
Start: 05/25/21
End: 12/08/21
Due: 12/08/22
Phase: N/A
Priority: Normal
Start: 10/09/17
End: 05/18/18
Due: 05/18/19